Want to see SE:CLS.B full AI Analyst Report?
Clinical Laserthermia Systems AB Class B (CLS.B) Income Statement
Clinical Laserthermia Systems AB Class B Income Statement
Last quarter (Q2 2026), Clinical Laserthermia Systems AB Class B's total revenue was $7.65M, a decrease of 18.28% from the same quarter last year. In Q2, Clinical Laserthermia Systems AB Class B's net income was $-12.09M. See Clinical Laserthermia Systems AB Class B’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 17.49M | $ 18.78M | $ 8.27M | $ 6.27M | $ 2.25M | |
| $ -29.00M | $ 10.42M | $ 3.00M | $ -2.79M | $ -3.63M | |
| $ 39.86M | $ 64.67M | $ 68.93M | $ 64.65M | $ 56.98M | |
| Depreciation and Amortization | $ 2.58M | $ 2.67M | $ 2.71M | $ 2.45M | $ 683.50K |
| $ -26.41M | $ -44.76M | $ -68.41M | $ -57.84M | $ -57.05M | |
| $ -29.00M | $ -54.25M | $ -65.93M | $ -67.44M | $ -60.68M | |
| $ -13.05M | $ 6.39M | $ -14.94M | $ -3.82M | $ -3.46M | |
| $ -42.05M | $ -47.86M | $ -80.88M | $ -71.27M | $ -64.14M | |
| $ -41.61M | $ -47.62M | $ -79.79M | $ -70.66M | $ -63.62M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.61 | $ -4.33 | $ -23.76 | $ -163.22 | $ -69.24 |
| Diluted EPS | $ -1.61 | $ -4.33 | $ -24.10 | $ -163.22 | $ -69.24 |
| Weighted Average Shares Outstanding | 25.87M | 11.01M | 3.36M | 432.92K | 287.59K |
| Weighted Average Shares Outstanding (Diluted) | 25.87M | 11.01M | 3.36M | 432.92K | 287.59K |
Currency in SEK